Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.145 AUD 3.57% Market Closed
Market Cap: 42.4m AUD

Next Science Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Next Science Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Free Cash Flow
-$8.6m
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Free Cash Flow
AU$35.3m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
Polynovo Ltd
ASX:PNV
Free Cash Flow
-AU$10.8m
CAGR 3-Years
-62%
CAGR 5-Years
-3%
CAGR 10-Years
-14%
SDI Ltd
ASX:SDI
Free Cash Flow
AU$10.3m
CAGR 3-Years
N/A
CAGR 5-Years
35%
CAGR 10-Years
13%
Ansell Ltd
ASX:ANN
Free Cash Flow
$170m
CAGR 3-Years
3%
CAGR 5-Years
-6%
CAGR 10-Years
4%
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Free Cash Flow
-$9.4m
CAGR 3-Years
25%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Next Science Ltd
Glance View

Market Cap
42.4m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
0.269 AUD
Undervaluation 46%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Free Cash Flow?
Free Cash Flow
-8.6m USD

Based on the financial report for Dec 31, 2024, Next Science Ltd's Free Cash Flow amounts to -8.6m USD.

What is Next Science Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
9%

Over the last year, the Free Cash Flow growth was 46%. The average annual Free Cash Flow growth rates for Next Science Ltd have been 2% over the past three years , 9% over the past five years .

Back to Top